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Abstract
Background: The large global burden of rheumatic heart disease (RHD) has come to light in recent years following
robust epidemiologic studies. As an operational research component of a broad program aimed at primary and
secondary prevention of RHD, we sought to determine the current prevalence of RHD in the country’s capital,
Lusaka, using a modern imaging-based screening methodology. In addition, we wished to evaluate the practicality
of training local radiographers in echocardiography screening methods.
Methods: Echocardiography was conducted on a random sample of students in 15 schools utilizing a previously
validated, abbreviated screening protocol. Through a task-shifting scheme, and in the spirit of capacity-building to
enhance local diagnostic and research skills, general radiographers based at Lusaka University Teaching Hospital
(UTH) were newly trained to use portable echocardiography devices. Students deemed as screen-positive were
referred for comprehensive echocardiography and clinical examination at UTH. Cardiac abnormalities were classified
according to standard World Heart Federation criteria.
Results: Of 1102 students that were consented and screened, 53 students were referred for confirmatory
echocardiography. Three students had definite RHD, 10 had borderline RHD, 29 were normal, and 11 students were
lost to follow-up. The rates of definite, borderline, and total RHD were 2.7 per 1000, 9.1 per 1000, and 11.8 per 1000,
respectively. Anterior mitral valve leaflet thickening and chordal thickening were the most common morphological
defects. The pairwise kappa test showed fair agreement between the local radiographers and an echocardiographer
quality assurance specialist.
Conclusion: The prevalence of asymptomatic RHD in urban communities in Zambia is within the range of results
reported in other sub-Saharan African countries using the WHF criteria. Task-shifting local radiographers to conduct
echocardiography was feasible. The results of this study will be used to inform ongoing efforts in Zambia to control
and eventually eliminate RHD.
Trial registration: The study was registered on clinicaltrials.gov (#NCT02661763).
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Background
Rheumatic heart disease (RHD) is a common and
neglected health problem in the developing world and
in indigenous regions of some high-income countries
[1, 2]. Greater than 33 million people have RHD and
nearly 320,000 die from the disease each year [3–5].
In sub-Saharan Africa, studies from multiple countries
report that approximately 0.5–3% of school-age
children have echocardiographic signs of definite or bor-
derline disease according to World Heart Federation
(WHF) criteria [6–9].
RHD is a preventable sequela of streptococcal pharyn-
gitis, commonly known as “strep throat.” A small percen-
tage of patients with untreated streptococcal pharyngitis
will develop autoimmune-mediated acute rheumatic fever
(ARF) and then RHD, which is characterized by heart
valve damage and progressive cardiac failure [10]. No
specific treatment for RHD exists but, if detected early,
continuous antibiotic prophylaxis (also known as “secon-
dary prevention” of RHD) can decrease ARF attack rates
and mitigate progression of heart disease [11–13]. Many
patients will eventually require complex pharmaceutical
regimens and surgical intervention [14]. Too often, RHD
leads to chronic morbidity and premature death [15].
RHD has been poorly addressed in Zambia. Prevalence
was estimated at 1.3% when measured nearly three
decades ago by auscultation [16]. In 2001, a review of
200 case notes for pediatric cardiac patients at Lusaka
University Teaching Hospital (UTH), Zambia’s main re-
ferral hospital, revealed that 70% were admitted for RHD
(J Musuku, unpublished data). Currently, UTH provides
services for approximately ten RHD outpatients each
week and on average five inpatients daily. There are no
specialized services for RHD available in the country
outside of Lusaka.
After receiving specialty training in paediatric cardiology
in South Africa, a UTH-based pediatrician mobilized aca-
demic colleagues, the Ministry of Health, local professional
societies, and a pharmaceutical company in a multi-faceted
effort to eliminate RHD in Zambia [17, 18]. Priorities of this
program were structured according to the “A.S.A.P.”
framework (Awareness-raising, Surveillance, Advocacy, and
Prevention) established by the Pan-African Society of
Cardiology as a strategy to reduce morbidity and mortality
associated with RHD in sub-Saharan Africa [19, 20].
As part of this effort, the prevalence of RHD was
measured in Zambian school children using handheld
echocardiography [21–23] and a recently validated
simplified screening protocol based on the WHF cri-
teria for echocardiographic diagnosis of RHD [24, 25].
In order to assure effective follow-up care for
students identified to have RHD, selected health
clinics in Lusaka were enrolled into a novel RHD
control program that consisted of training, ongoing
supportive supervision, and maintenance of adequate
medicine stores [26, 27].
The opportunity of this study was also used to build
local echocardiographic capabilities that could be applied
to subsequent clinical and research activities in Zambia
[28]. Data from this investigation were anticipated to in-
form health programs combating RHD and to support
advocacy for RHD patients.
Methods
Study design and oversight
This was an observational cross-sectional study designed to
measure the prevalence of RHD in school children in
Lusaka, the capital of Zambia. The study was registered on
clinicaltrials.gov (#NCT02661763) and approved by the Bio-
medical Research Ethics Committee at the University of
Zambia, the Ministry of Health, the Ministry of Education,
and the Ministry of Community Development, Mother and
Child Health. Data collection took place between September
and December in 2015.
Study population
The study population was drawn from a random sample
of children in grades seven through twelve attending
basic, secondary, and high schools in Lusaka. Screening
was focused on older school children (rather than
younger school children) based on evidence that they
are at higher risk of RHD [9, 29, 30].
Written informed consent for participation in the
study was required from parents or legal guardians. In-
formation about the study and consent forms were sent
home with students several weeks before each screening
session. Consent forms were written in English, Nyanja
and Bemba, which are the most common languages in
Lusaka. Children were also verbally informed about the
study at the time of screening and were required to
provide written assent with their name or thumbprint in
order to participate.
Inclusion criteria were all children whose parents con-
sented, who provided assent, and who were present at
the time the screening was conducted. Exclusion criteria
included conditions that precluded the performance of
transthoracic echocardiography (e.g., skin infection of
the chest).
A member of the study team approached the adminis-
trative head of each selected school to invite their school
to participate. Awareness messages (flyers and posters)
that described the study were distributed, and study staff
briefed teachers whose classrooms were to be involved.
The classrooms selected to participate in each school
were determined at random and approximately 60–80
students were enrolled from each school.
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Study procedures
Prior to screening, each participant’s parent or guardian
completed a questionnaire that collected information on
demographics and the participant’s general health his-
tory. On the day of screening, the study team (consisting
of a field coordinator, pediatric nurses, radiographers,
data entry staff, and sometimes a physician) organized a
private screening area and ensured that a member of the
school staff would be present during interactions
between study staff and participants.
Study staff conducted a focused history and physical
examination with each participant, specifically to assess
for pharyingitis, RF, or RHD. Study staff then performed
a screening echocardiogram using the abbreviated
screening protocol and a handheld ultrasound device
(Fig. 1). The overall process generally lasted 15–20 min
for each participant; the echocardiographic screening
component lasted about 5 min per participant. Refresh-
ments were provided after the screening. The study staff
prioritized flexibility in scheduling so that interruption
of regular school activities was minimized.
“eRegister” database
Data obtained at the time of screening was entered
through mobile electronic devices (Samsung Galaxy 4
Tab computer tablets) into a digital system (“eRegister”)
that was developed specifically for the study [31]. The
system used a well-established e-health platform
(“CommCare” by Dimagi) [32, 33], which includes a
customizable mobile health data collection application
and an online portal for secure data viewing and repor-
ting. All access to the digital platform including mobile
submissions was done over HTTPS (hypertext transfer
protocol secure) and was cryptographically secure.
Mobile devices were password-locked. Echocardiograms
were also saved in the system; images and videos were
temporarily stored on the hard drive of the ultrasound
device and then transferred to the eRegister.
Echocardiographer training
Six general radiographers from UTH were recruited to
participate in the school screening study, and three
ultimately completed training and remained part of the
study team throughout the study period. Training
comprised classroom-style and hands-on workshops in-
volving actual RHD patients at UTH and supportive
supervision during school screening [28]. Training acti-
vities took place periodically over 12 months beginning
May 2014. Training was structured to accommodate the
practical considerations of trainees, who continued to
work as general radiographers at UTH.
Radiographers were trained to use a handheld machine
(General Electric V-Scan, General Electric Company,
Fairfield, CT, USA) and to screen participants for evi-
dence of RHD using a recently validated, simplified
protocol called FOCUS (an acronym for FOCused
method Utilizing hand-held echocardiography in
Screening for RHD) [24]. This protocol incorporates key
aspects of the much more complex (and definitive)
WHF protocol for echocardiography-based RHD
diagnosis.
The abbreviated protocol utilizes a single view (the
parasternal long-axis view) and a single measurement
(regurgitation jet in the mitral valve, which is implicated
in most RHD cases). According to the protocol, the mi-
tral valve is interrogated, first without and then with
color Doppler. A regurgitation jet-length greater or
equal to 2 cm (measured from the vena contracta to the
last pixel of the regurgitant jet using the V-Scan radius
measuring tool) constitutes a positive result.
Following the first intensive training of radiographers that
started in May 2014, school screening initially began in
October 2014. However, quality assurance checks by study
investigators (JM, LZ) revealed suboptimal performance by
the newly trained radiographers. The study was put on hold
pending additional training and practice. The study
re-started in September 2015 after the radiographers’ profi-
ciency was confirmed through quality assurance checks by
a blinded external expert (described below). Improvement
in radiographers’ performance was attributed to repeated
practice, real-time guidance during periodic visits by
volunteer echocardiography technicians from abroad, and
training with the assistance of RHD patients at UTH.
When the study re-started, two mechanisms were
implemented to help ensure successful screening: (1)
four international echocardiography technicians spent a
total of 8 weeks accompanying study staff during school
screening to support the work of local radiographers;
and (2) all screening echocardiograms were reviewed
Fig. 1 A radiographer from Lusaka University Teaching Hospital uses
ultraportable echocardiography to screen an adolescent for rheumatic
heart disease as part of the study (photograph used with permission
of participant)
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remotely by a professional third-party echocardiographer
(VirtualScopics, University of Rochester, USA) who
accessed de-identified scans through the eRegister and
conducted independent review of the echocardiograms
recorded by the field team.
Screening and confirmatory echocardiography
Echocardiographic screening was performed using
V-Scan handheld machines. If a participant screened
positive at the school or through the VirtualScopics
quality assurance (VSQA) review, study staff informed
the participant’s parents or guardians and arranged
follow-up at UTH where a member of the study team
(JM) performed comprehensive echocardiography using
a standard portable ultrasound machine (Philips CX 50
or Sonosite M-Turbo).
The follow-up echocardiogram was conducted accor-
ding to evidence-based consensus WHF guidelines [25]
using 2D, continuous-wave, and color-Doppler to assess
for morphological abnormalities or pathological mitral
or aortic valve regurgitation. The echocardiograms of
participants that underwent follow-up echocardiography
were classified as “normal,” “definite RHD,” or “border-
line RHD.”
As described by WHF, definite RHD corresponds to
echocardiographic changes that are likely to be rheum-
atic in origin assuming the clinical context is consistent.
Borderline RHD corresponds to echocardiographic
changes that may represent early RHD in individuals
aged 20 years or less. The borderline category was estab-
lished by WHF because young people may benefit from
early detection of RHD and initiation of antibiotic
prophylaxis [25]; progression of heart disease in patients
with borderline RHD has been documented [34, 35].
Student disposition
Participant disposition was determined by the results of
school screening and confirmatory echocardiography
(Fig. 2). No follow-up was required if the focused history
and physical examination, the screening echocardio-
gram, and the VSQA review were normal.
When the physical examination revealed pharyngitis
and the screening echocardiogram/VSQA review was
normal, the participant was referred to UTH or a local
health clinic for further evaluation and management, in-
cluding primary prevention of RHD. When the screening
echocardiogram revealed any abnormality, or there was
a clinical suspicion of ARF, the participant was referred
to UTH for a comprehensive evaluation and quantitative
echocardiogram in order to assess for ARF or RHD. Par-
ticipants with definite or borderline RHD were referred
to the pediatric cardiology clinic at UTH or a local
health clinic for long-term follow-up including antibiotic
prophylaxis and repeat echocardiography on a 6- or
12-monthly basis [14, 34].
Participants with cardiac abnormalities due to con-
genital heart disease or other non-rheumatic problems
(for example, skin or dental problems) were referred for
Fig. 2 Student disposition in study methodology
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follow-up evaluation and treatment at UTH or their
local clinic in accordance with standard medical care in
Zambia.
RHD control program in health clinics
Participants that were identified to have borderline or
definite RHD were referred for follow-up management
which included the recommendation for antibiotic
prophylaxis (with oral penicillin or monthly injections of
benzathine penicillin) according to national guidelines.
Penicillin-allergic individuals were alternatively offered
erythromycin. UTH was an inconvenient location for
some participants to routinely travel for follow-up and
therefore selected health clinics in Lusaka that were lo-
cated near the study schools were enrolled in an RHD
control program [27].
As part of this program, study nurses and physicians
conducted an introductory on-site training workshop, dis-
seminated educational materials to staff and patients, and
performed monthly or bi-monthly supportive supervisory
visits. The training taught knowledge and skills to support
effective primary prevention (i.e., treatment of bacterial
pharyngitis with a single dose of benzathine penicillin to
decrease risk of RF), secondary prevention (i.e., continuous
antibiotic prophylaxis in children with RHD to mitigate
progression of heart disease), and pharmacovigilance. De-
tails of the training are described previously [26]. Reliable
availability of high-quality benzathine penicillin at UTH
and participating clinics in Lusaka was faciliated by a pro-
duct grant to the Ministry of Health by Sandoz, the
generics division of Novartis.
Sample size considerations
The total school population in Lusaka within which the
study took place is approximately 500,000. Since previous
studies demonstrated that RHD prevalence increases in
older children [9, 29, 30], this study focused on prevalence
in children attending grades 7 and above. A minimum
sample size of 1024 participants in 15 randomly selected
schools was calculated based on precision around a point
estimate of 1% RHD prevalence in Lusaka. This was felt to
be a conservative estimate in light of similar studies from
other countries in sub-Saharan Africa [8, 29, 30, 36]. The
sample size also accounted for a presumed rejection rate
of 9%. With this sample, it was determined that the preva-
lence of RHD could be estimated within 0.7 percentage
points of precision with 95% confidence. A 1.2 design ef-
fect due to clustering in the sampling design was assumed
given that some participants were enrolled from within
clusters (i.e., participants enrolled from the same class-
rooms and schools were more likely to be similar in unin-
tended ways relative to a completely random population).
Variation in the total number of eligible individuals in
each school was expected, as was the total size of each
school. We accounted for this variation in the sampling
process by weighting the primary sampling unit (the
school) and selecting according to size, using probability
proportional to size (PPS) sampling [37]. The sampling
weights were also used in the analysis to control for pos-
sible misspecifications of standard errors in each cluster.
As discussed above, the study was temporarily halted
early on to allow for improved training of radiographers.
A formal assessment of radiographers’ performance
using the screening protocol was then conducted by
VSQA review, and schools were re-randomized prior to
re-starting the study. Fifteen schools included in the
study were randomly selected from a Ministry of Educa-
tion database of all 119 basic, secondary, and high
schools in Lusaka. Within each randomly selected
school, one grade was randomly selected (grades 7–12).
Multiple classrooms in the selected grade were then ran-
domly selected with the aim to enroll a minimum of 60
students per school. All students in the selected class-
rooms were eligible to participate if consent and assent
were completed.
Analysis plan
The study measured prevalence expressed as a proportion
per 1000 individuals using standard statistical analysis
tools. The estimate of the standard error accounted for
clustering effects and was considered in the confidence
interval computation. Sub-analyses using a similar
approach were conducted by age, gender, and selected
additional demographic parameters, though it was not ex-
pected that these variables would have adequate power for
precise estimates of prevalence for these subgroups. Cat-
egorical data were compared by chi-squared analyses,
chi-squared for trend, or expressed as risk ratios with 95%
confidence intervals as appropriate. To assess the reliabil-
ity of the training program in skills-building for the local
radiographers, a pairwise kappa test was performed.
Results
The sample population consisted of 2276 students in 15
schools that were eligible for participation. Consent was
attempted for 2116 students that were in attendance in
school on the day that consent forms were distributed
(160 students were absent on that day). A total of 1102
students ultimately advanced through the consent
process and underwent echocardiographic screening as
part of the study (Fig. 3).
Sociodemographic characteristics of students included
in the study revealed a slight predominance of female
participants, and a majority of students from lower so-
cioeconomic strata as determined by the neighborhood
in which they lived (Table 1).
Most (86%) students were aged 13–18 years. Ten stu-
dents were identified by study nurse-coordinators to
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have pharyngitis at the time of screening and were re-
ferred for medical follow-up. Fifteen students were
found to have other medical problems during screening
(including dental caries and rashes) and were also re-
ferred for medical evaluation. One student was found by
screening echocardiography to have congenital heart
disease.
Fifty-three students screened positive for RHD by
portable echocardiography at schools and were referred
for comprehensive echocardiography at UTH. Of those,
42 students followed-up and received confirmatory
echocardiography. There were no gender differences in
the cohort of children that screened positive. On
confirmatory echocardiography, it was found that 3
students met WHF criteria for definite RHD, 10
students met criteria for borderline RHD, and 29
students did not meet criteria for any category of
RHD. The confirmed prevalences of definite, border-
line, and total RHD were therefore 2.7 per 1000
(95% CI 0.6–8.0), 9.1 per 1000 (95% CI 3.8–15.6),
and 11.8 per 1000 (95% CI 5.7–15.6), respectively.
Despite extensive and prolonged efforts by the study
coordinators to follow-up students that screened
positive, eleven students were lost to follow-up
between the time they screened positive at schools
and the time of a comprehensive echocardiographic
assessment at UTH.
Demographic and clinical characteristics of the stu-
dents that were diagnosed with definite and borderline
RHD are shown in Table 2.
Each of these students had abnormalities of the mitral
valve, with the most commonly observed abnormal mor-
phological features being anterior mitral valve leaflet
thickening and chordal thickening. The aortic valve was
not affected in this group of students.
Prior to the main study initiation a formal assessment
of the capabilities of the local radiographers to success-
fully implement the abridged echocardiographic screen-
ing protocol was conducted. The echocardiograms of
471 students screened by the local radiographers were
reviewed by the VirtualScopics quality assurance
(VSQA) specialist. The pairwise kappa test showed fair
agreement between the local radiographers and the
VSQA quality assurance radiographer (agreement, 97%;
ϰ = 0.54; SE = 0.11). The results are listed in Table 3.
Of the 53 students referred for comprehensive echo-
cardiography at UTH, 24 had screened negative at the
school screening but the VSQA review indicated mitral
Fig. 3 Flowchart of schools of students involved in the study
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regurgitation with jet length ≥ 2 cm in at least one view.
From this cohort, 18 students followed-up with a con-
firmatory echocardiogram resulting in the diagnosis of
one definite RHD and five borderline RHD cases. There
was concordance between the local radiographers and
the VSQA review for 28 students that screened positive,
and 23 of these students followed-up with a confirma-
tory echocardiogram that resulted in the diagnosis of
two definite RHD and five borderline RHD cases. One
student screened positive at school and the VSQA re-
view was negative; the confirmatory echo diagnosis was
normal.
Discussion
This study found a RHD prevalence of 11.8 per 1000 in
Zambian school children. In addition, this study demon-
strated the practicality of successfully training radiogra-
phers in echocardiography-based screening. The main
finding that 1.2% of school children have evidence of
Table 1 Sociodemographic characteristics of 1102 students
screened for RHD in Lusaka, Zambia
Characteristic n(%)
Gender
Female 590 (54)
Male 512 (46)
Age (years)
Mean (SD) 15.4 (1.9)
Median 15
10–12 48 (4.4)
13–15 506 (45.9)
16–18 443 (40.2)
19–21 40 (3.6)
22–24 2 (0.2)
Unobserved 63 (5.7)
Socioeconomic status
Lower 658 (59.7)
Higher 330 (29.9)
Unobserved 114 (10.3)
Schools
Basic schools
Yotam Muleya 102 (9.3)
Namando 86 (7.8)
State Lodge A 62 (5.6)
Hillside 71 (6.4)
Kaunda Square 74 (6.7)
Kalingalinga 21 (1.9)
Lotus 75 (6.8)
Twashuka 52 (4.7)
Kamulanga 86 (7.8)
Secondary schools
Matero 123 (11.2)
Nyumba Yanga 100 (9.1)
High schools
St. Patrick Girls 91 (8.3)
Kamulanga 36 (3.3)
Munali Boys 51 (4.6)
Kabulonga Boys 72 (6.5)
Table 2 Demographic and clinical characteristics of 13 students
identified to have definite and borderline RHD
Characteristic n (%)
Gender
Female 8 (62)
Male 5 (38)
Age (years)
Mean (SD) 15.3 (1.9)
Median 16
Range 13–18
Socioeconomic status
Lower 10 (77)
Higher 1 (8)
Unobserved 2 (15)
Definite RHD criteria met [25]
Pathological MR and at least two morphological
features of RHD of the MV
3
MS mean gradient ≥ 4 mmHg 0
Pathological AR and at least two morphological
features of RHD of the AV
0
Borderline disease of both the AV and MV 0
Borderline RHD criteria met [25]
At least two morphological features of RHD of
the MV without pathological MR or MS
0
Pathological MR 10
Pathological AR 0
Acronyms, AR atrial regurgitation, AV atrial valve, MR mitral regurgitation, MS
mitral stenosis, MV mitral valve, SD standard deviation
Table 3 Measurement of performance of local radiographers in
echocardiography-based screening (“negative” refers to a
normal screening evaluation; “positive” refers to a screening
evaluation that is abnormal)
Number of screening
tests
Local
radiographers
Quality assurance
specialist
450 Negative Negative
12 Negative Positive
8 Positive Positive
8 Positive Negative
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borderline or definite RHD is consistent with investiga-
tions using similar methodologies in urban settings of
other sub-Saharan African countries (Table 4).
The finding is also similar to the single previous
estimate of RHD in Zambia that was obtained several
decades ago albeit that study used different screening
(auscultation alone) and diagnostic criteria (not utilizing
current World Heart Federation criteria) [16]. It is not-
able that this research did not take place in isolation; ra-
ther, from the start it was incorporated into a broader
health systems strengthening program that included the
majority of government health clinics in Lusaka and
aims to provide tailored support for the prevention and
treatment of RHD in Zambia.
We trained radiography technicians that had little or no
previous experience with echocardiography to perform
school-based screening. This was necessary because health
workers in Lusaka are not skilled in cardiac echocardiog-
raphy except for a few health professionals at UTH. The
feasibility of task-shifting simple echocardiographic
screening protocols to non-expert health workers has
been demonstrated in similar settings [38–41]. In Zambia,
this approach necessitated greater resources to conduct
training and assess their results, and it also delayed the
study until the quality of the screening echocardiograms
could be assured. However, the study team felt strongly
about this approach as the investment in time and re-
sources was viewed as a method for building local echo-
cardiographic capabilities to support subsequent clinical
and research activities in Zambia. Hence the screening for
each student involved in the study was conducted by a
local radiographer. Ultimately, the performance of the
local radiographers in the study was characterized by sig-
nificant inconsistencies when compared with the VSQA
quality assurance review. Without the VSQA review,
the school screening process would have missed
nearly half of the students diagnosed with definite or
borderline RHD. The challenges that were faced in
providing local radiographers with the skills required
to confidently and independently conduct screenings
for RHD will be an important consideration in related
future research in Zambia and may have implications
Table 4 Summary of RHD prevalence studies using echocardiography conducted in sub-Saharan Africa. More than 27,000 children
have been screened for RHD using echocardiography in this region. The variability in findings of RHD prevalence between countries
is not fully understood
Year
reported
Country (location) Population studied Methodology RHD prevalence
1996 Kenya (Eldoret) [49] 1150 school children in grades
1–8 in two schools
Colour-flow echocardiography and a
portable generator using
investigator-defined criteria
Definite 0.3%
2007 Mozambique (Maputo) [30] 2170 randomly selected children
aged 6–17 years in six schools
Portable echocardiography at schools
using investigator-defined criteria
3%
2012 Uganda (Kampala) [29] 4869 children aged 5–16 years in
six randomly selected schools
Portable echocardiography at schools
using 2006 WHO/NIH criteria
Possible 1%;
probable 0.4%;
definite 0.2%
2014 Eritrea (multiple cities) [50] 684 adolescents aged 13–24
randomly selected from nine
schools
Portable echocardiography at schools
using investigator-defined criteria
Suspected 3.3%;
definite 4%
2015 Senegal (Dakar) [36] 2019 children aged 5–18 years
in 16 schools
Portable echocardiography at schools
using WHF criteria
Borderline 1.1%;
definite 0.05%
2015 Ethiopia (Jimma) [8] 2000 children aged 4–24 years
from randomly selected schools
Echocardiography at a university-affiliated
field research center using WHF criteria
Borderline 1.4%;
definite 1.7%
2015 South Africa
(Cape Town) [8]
2720 children aged 4–24 years
in randomly selected schools
Portable echocardiography in a mobile
clinic using WHF criteria
Borderline 1.5%;
definite 0.5%
2015 South Africa (Free State
and Northern Cape) [51]
1015 children aged 14–22 years
in grades 10–12
Portable echocardiography at schools
using investigator-defined criteria
Definite 0.5%
2016 Malawi (Lilongwe) [7] 1450 children aged 5–16 years in
three schools and surrounding
communities
Portable echocardiography at schools
and in surrounding communities using
WHF criteria
Borderline 2.7%;
definite 0.7%
2016 Uganda (Kampala) [52] 488 HIV-infected children aged
5–18 years from an outpatient
clinic
Echocardiography at medical centers
using WHF criteria
Borderline 0.4%;
definite 0.4%
2016 Ethiopia (6 cities) [6] 3238 children aged 6–18 years
in 28 randomly selected schools
Portable echocardiography at schools
using WHF criteria
Borderline 0.5%;
definite 1.4%
2017 Rwanda (Gasabo district) [53] 2501 children aged 6–16 years
in 10 schools
Portable echocardiography at schools
using WHF criteria
Borderline 0.5%;
definite 0.2%
Schwaninger et al. BMC Cardiovascular Disorders  (2018) 18:135 Page 8 of 12
for the design of similar research programs in other
countries.
Various simplified echocardiography protocols have
been utilized to facilitate population-based screening for
asymptomatic RHD [42, 43], and these are now being
used in conjunction with ultra-portable handheld echo-
cardiography devices in an effort to further streamline
the screening process [44, 45]. In this study we used the
recently validated FOCUS screening protocol, which was
previously shown in a controlled investigation to be 92%
sensitive and 100% specific for definite RHD [24]. This
protocol, which utilizes a single view and measurement,
was particularly advantageous in the current study in
which screening was conducted by general radiographers
who lacked echocardiography experience. Of the 42 stu-
dents that screened positive and underwent comprehen-
sive follow-up echocardiography, 31% (n = 13) were
diagnosed with definite or borderline RHD according to
WHF criteria. We attribute the decreased specificity to
“real-world” factors that include uncertainty with some
measurements obtained in the “field” (i.e., at schools)
and the motivation by first-time study radiographers and
coordinators to be conservative in their screening assess-
ments of children to minimize the risk of missing a stu-
dent who may have RHD. The number of referred
patients for confirmatory echocardiography did not im-
pose an excessive burden on the study team.
Just over half of students that received a consent form
and questionnaire were ultimately screened (Fig. 3). Of
the consent forms that were distributed to school chil-
dren to take home to their parents, 36% were not
returned or were returned blank. Nine percent of fam-
ilies opted out of participation. The consent form in-
cluded a questionnaire with 11 questions to obtain
demographic information and the child’s health history,
with a focus on the incidence and treatment of sore
throat. We hypothesize that completing the question-
naire may have been perceived as burdensome to some
parents/guardians. Also, students may have forgotten to
give the form to their parents, or failed to bring a com-
pleted form back to school. Absenteeism was also a fac-
tor on screening day (5.7% of students).
A novel education and training program was, for the
first time in Zambia, implemented in Lusaka clinics by
the study team in order to assure appropriate follow-up
clinical care for participants identified through the study
to have RHD [26]. The program comprised an intro-
ductory on-site training workshop, dissemination of edu-
cational materials for staff and patients, ongoing
supportive supervisory visits by UTH staff, and assess-
ment of antibiotic stocks with replenishment of
benzathine penicillin when necessary. Key elements of
the program included guidance on when and how to
administer secondary antibiotic prophylaxis, how to
manage the unlikely event of penicillin allergy, and how
to deliver primary prevention of RHD (i.e., detection and
proper treatment of bacterial pharyngitis). At the time of
the investigation eight clinics were enrolled that were se-
lected specifically due to their geographic proximity to
study schools. Since then the program has grown to in-
clude all 29 government clinics in the Lusaka municipal-
ity, and activities are underway to expand the RHD
control program to other provinces beyond Lusaka. Fu-
ture work will involve the exploration of innovative ways
to scale up the RHD control program (such as the use of
electronic training modules), and to provide broad ac-
cess to educational materials through the Pan African
Society of Cardiology (PASCAR).
Borderline RHD is an echocardiography-based diag-
nostic category established in recent years by the World
Heart Federation to improve the sensitivity of early de-
tection of RHD in individuals ≤ 20 years [25]. In theory,
early diagnosis paves the way for clinical interventions
that prevent or mitigate disease progression, although
this has not been proven in practice [46]. Because this
category is new and its natural history is not yet fully
understood, a major research priority has been to deter-
mine optimal management of individuals with borderline
RHD. In the current study participants with borderline
RHD were offered antibiotic prophylaxis along with rou-
tine clinical follow-up and periodic echocardiography, an
approach that was taken in some previously described
programs [6, 8] and not others [7, 47]. A recent pro-
spective observational study of 34 school children in
South Africa diagnosed with borderline RHD were
followed up after 5 years [48]; 16% continued to have
borderline RHD and 16% progressed to definite RHD,
which suggests that initiation of antibiotic prophylaxis in
children with borderline disease may have clinical bene-
fit if antibiotic prophylaxis prevents progression of latent
RHD. A similar conclusion was drawn in a prospective
cohort study of indigenous Australian children with bor-
derline RHD who were found to be at increased risk of
progression to definite RHD [34]. At this time the ap-
proach in Zambia is to initiate antibiotic prophylaxis in
individuals with borderline RHD and to discontinue
prophylaxis on a case-by-case basis according to each
patient’s clinical evolution. We will refine these tactics as
new data and recommendations from leading health au-
thorities become available.
There were some limitations in this study. Eleven par-
ticipants who screened positive for RHD at schools were
lost to follow-up. In most cases, parents or guardians
were successfully contacted but ultimately could not be
persuaded to bring their children for a confirmatory
echocardiogram at UTH. This was despite offers of
travel reimbursement and numerous attempts over three
months or more by study staff to facilitate follow-up,
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including repeated telephone calls and in-person visits
back to schools to discuss with families and school staff.
In many cases, appointments were made for follow-up
visits but not kept. If future screening studies are
conducted in Zambia, we aim to incorporate on-site
confirmatory echocardiography such that definitive diag-
noses can be made at the time of screening and obviate
the need for subsequent visits. Another limitation of the
study is that the population screened was limited to
school-going children in the urban setting of Zambia’s
capital; this group may not be representative of the en-
tire country. The study was limited to Lusaka mainly be-
cause of resource considerations, including clinical staff
that would be available to conduct the study. Access to
healthcare is generally accepted to be greater in Lusaka
than in rural and remote regions of the country, which
may result in improved treatment of streptococcal pha-
ryngitis and prevention of RF and RHD. Indeed, more
patients with RHD are reportedly referred to UTH from
communities that are located outside of Lusaka, al-
though there is not yet a national patient registry or sur-
veillance system in place. Finally, while the screening
protocol was associated with a validated sensitivity above
90%, there remains the possibility that some participants
with potential RHD erroneously screened negative which
would have led to an underestimation of the disease
prevalence in the population studied.
Conclusions
The prevalence of RHD in Zambia is similar to that reported
in neighboring countries and other low-resource settings
globally. This information is being used to inform ongoing
advocacy and education efforts designed for local health au-
thorities, health workers, and the public. The abbreviated
echocardiography screening protocol performed well in
practice and may be considered for use in future prevalence
studies. The conduct of this investigation was viewed as an
opportunity to incorporate capacity-building for the local
radiographers and to launch primary and secondary preven-
tion programs in local clinics. The authors recommend pri-
oritizing this approach whenever possible, even if it requires
greater investment in time and other resources.
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